المؤلفون: Gillot C; Department of Pharmacy, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium., Tré-Hardy M; Department of Pharmacy, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium; Department of Laboratory Medicine, Hopital Iris Sud, Brussels, Belgium; Faculty of Medicine, Université libre de Bruxelles, Brussels, Belgium., Cupaiolo R; Department of Laboratory Medicine, Hopital Iris Sud, Brussels, Belgium., Blairon L; Department of Laboratory Medicine, Hopital Iris Sud, Brussels, Belgium., Wilmet A; Department of Laboratory Medicine, Hopital Iris Sud, Brussels, Belgium., Beukinga I; Department of Laboratory Medicine, Hopital Iris Sud, Brussels, Belgium., Dogné JM; Department of Pharmacy, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium., Douxfils J; Department of Pharmacy, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium; Qualiblood s.a., Research and Development Department, Namur, Belgium. Electronic address: jonathan.douxfils@unamur.be., Favresse J; Department of Pharmacy, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium; Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.

المصدر: Virology [Virology] 2024 Jul; Vol. 595, pp. 110082. Date of Electronic Publication: 2024 Apr 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0110674 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0341 (Electronic) Linking ISSN: 00426822 NLM ISO Abbreviation: Virology Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Neutralizing*/immunology , Antibodies, Neutralizing*/blood , 2019-nCoV Vaccine mRNA-1273*/immunology , 2019-nCoV Vaccine mRNA-1273*/administration & dosage , COVID-19*/immunology , COVID-19*/virology , COVID-19*/prevention & control , Antibodies, Viral*/immunology , Antibodies, Viral*/blood , SARS-CoV-2*/immunology , SARS-CoV-2*/genetics , Health Personnel* , Immunization, Secondary* , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage, Humans ; Male ; Female ; Adult ; Middle Aged ; BNT162 Vaccine/administration & dosage ; BNT162 Vaccine/immunology ; Spike Glycoprotein, Coronavirus/immunology ; Spike Glycoprotein, Coronavirus/genetics ; Breakthrough Infections

SCR Disease Name: COVID-19 breakthrough infections

SCR Organism: SARS-CoV-2 variants

المؤلفون: Roozen GVT; Department of Infectious Diseases, Leiden University Centre for Infectious Diseases (LUCID), Leiden University Medical Centre (LUMC), Leiden, The Netherlands; Department of Parasitology, LUCID, LUMC, Leiden, The Netherlands. Electronic address: G.V.T.Roozen@lumc.nl., Prins MLM; Department of Infectious Diseases, Leiden University Centre for Infectious Diseases (LUCID), Leiden University Medical Centre (LUMC), Leiden, The Netherlands., Prins C; Department of Infectious Diseases, Leiden University Centre for Infectious Diseases (LUCID), Leiden University Medical Centre (LUMC), Leiden, The Netherlands., Janse JJ; Department of Parasitology, LUCID, LUMC, Leiden, The Netherlands., de Gruyter HLM; Department of Medical Microbiology, LUCID, LUMC, Leiden, The Netherlands., Pothast CR; Department of Hematology, LUMC, Leiden, The Netherlands., Huisman W; Department of Parasitology, LUCID, LUMC, Leiden, The Netherlands., Koopman JPR; Department of Parasitology, LUCID, LUMC, Leiden, The Netherlands., Lamers OAC; Department of Parasitology, LUCID, LUMC, Leiden, The Netherlands., Kuijer M; Department of Immune Surveillance, National Institute for Public Health and the Environment (RIVM), Utrecht, The Netherlands., Myeni SK; Department of Medical Microbiology, LUCID, LUMC, Leiden, The Netherlands., van Binnendijk RS; Department of Immune Surveillance, National Institute for Public Health and the Environment (RIVM), Utrecht, The Netherlands., Hartog GD; Department of Immune Surveillance, National Institute for Public Health and the Environment (RIVM), Utrecht, The Netherlands; Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands., Heemskerk MHM; Department of Hematology, LUMC, Leiden, The Netherlands., Jochems SP; Department of Parasitology, LUCID, LUMC, Leiden, The Netherlands., Feltkamp MCW; Department of Medical Microbiology, LUCID, LUMC, Leiden, The Netherlands., Kikkert M; Department of Medical Microbiology, LUCID, LUMC, Leiden, The Netherlands., Rosendaal FR; Department of Clinical Epidemiology, LUMC, Leiden, The Netherlands., Roestenberg M; Department of Infectious Diseases, Leiden University Centre for Infectious Diseases (LUCID), Leiden University Medical Centre (LUMC), Leiden, The Netherlands; Department of Parasitology, LUCID, LUMC, Leiden, The Netherlands., Visser LG; Department of Infectious Diseases, Leiden University Centre for Infectious Diseases (LUCID), Leiden University Medical Centre (LUMC), Leiden, The Netherlands., Roukens AHE; Department of Infectious Diseases, Leiden University Centre for Infectious Diseases (LUCID), Leiden University Medical Centre (LUMC), Leiden, The Netherlands.

المصدر: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Jul; Vol. 30 (7), pp. 930-936. Date of Electronic Publication: 2024 Mar 28.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691 (Electronic) Linking ISSN: 1198743X NLM ISO Abbreviation: Clin Microbiol Infect Subsets: MEDLINE

مواضيع طبية MeSH: 2019-nCoV Vaccine mRNA-1273* , Immunization, Secondary*/methods , COVID-19*/prevention & control , COVID-19*/immunology , Antibodies, Viral*/blood , SARS-CoV-2*/immunology , Immunogenicity, Vaccine* , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , COVID-19 Vaccines*/adverse effects , Antibodies, Neutralizing*/blood, Humans ; Adult ; Injections, Intradermal ; Male ; Female ; Young Adult ; Adolescent ; Injections, Intramuscular ; Vaccination/methods

المؤلفون: Kikuchi J; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Kondo Y; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Kojima S; Keio University School of Medicine, Tokyo, Japan., Kasai S; Keio University School of Medicine, Tokyo, Japan., Sakai Y; Keio University School of Medicine, Tokyo, Japan., Takeshita M; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Hiramoto K; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Saito S; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Fukui H; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Hanaoka H; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Suzuki K; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Kaneko Y; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.

المصدر: Immunological medicine [Immunol Med] 2024 Jun; Vol. 47 (2), pp. 76-84. Date of Electronic Publication: 2024 Jan 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa UK Limited Country of Publication: England NLM ID: 101736847 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2578-5826 (Electronic) Linking ISSN: 25785826 NLM ISO Abbreviation: Immunol Med Subsets: MEDLINE

مواضيع طبية MeSH: Lupus Erythematosus, Systemic*/immunology , COVID-19*/prevention & control , COVID-19*/immunology , BNT162 Vaccine*/administration & dosage , BNT162 Vaccine*/adverse effects , BNT162 Vaccine*/immunology , SARS-CoV-2*/immunology , 2019-nCoV Vaccine mRNA-1273*/administration & dosage , 2019-nCoV Vaccine mRNA-1273*/adverse effects , 2019-nCoV Vaccine mRNA-1273*/immunology , Antibodies, Neutralizing*/blood, Humans ; Female ; Male ; Adult ; Middle Aged ; COVID-19 Vaccines/adverse effects ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/immunology ; Symptom Flare Up ; Vaccination/adverse effects ; Antibodies, Viral/blood ; Severity of Illness Index ; Antibodies, Antinuclear/blood ; Antibodies, Antinuclear/immunology

المؤلفون: Soe P; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, Canada; School of Population and Public Health, University of British Columbia, Vancouver, Canada., Wong H; School of Population and Public Health, University of British Columbia, Vancouver, Canada., Naus M; School of Population and Public Health, University of British Columbia, Vancouver, Canada; BC Center for Disease Control, Vancouver, British Columbia, Canada., Muller MP; Department of Medicine, Unity Health Toronto, Toronto, Canada., Vanderkooi OG; Department of Pediatrics and Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Canada., Kellner JD; Department of Pediatrics and Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Canada., Top KA; Canadian Center for Vaccinology, IWK Health and Department of Pediatrics, Dalhousie University, Halifax, Canada., Sadarangani M; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, Canada; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada., Isenor JE; Canadian Center for Vaccinology, IWK Health and Department of Pediatrics, Dalhousie University, Halifax, Canada., Marty K; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, Canada., De Serres G; CHU de Québec-Université Laval, Québec City, Canada., Valiquette L; Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Canada., McGeer A; Department of Microbiology, Sinai Health, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., Bettinger JA; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, Canada; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada. Electronic address: jbettinger@bcchr.ubc.ca.

مؤلفون مشاركون: Canadian Immunization Research Network

المصدر: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3819-3829. Date of Electronic Publication: 2024 May 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19*/epidemiology , BNT162 Vaccine*/administration & dosage , BNT162 Vaccine*/adverse effects , COVID-19 Vaccines*/adverse effects , COVID-19 Vaccines*/administration & dosage , 2019-nCoV Vaccine mRNA-1273* , SARS-CoV-2*/immunology, Humans ; Aged ; Male ; Female ; Canada ; Aged, 80 and over ; Vaccination/adverse effects ; Hospitalization/statistics & numerical data

المؤلفون: Horne EMF; From the Population Health Sciences, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom.; National Institute of Health and Care Research Bristol Biomedical Research Centre, Bristol, United Kingdom., Hulme WJ; The Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom., Parker EPK; London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom., Keogh RH; London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom., Williamson EJ; London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom., Walker VM; From the Population Health Sciences, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom.; MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Palmer TM; From the Population Health Sciences, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom.; MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Denholm R; From the Population Health Sciences, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom.; National Institute of Health and Care Research Bristol Biomedical Research Centre, Bristol, United Kingdom.; Health Data Research UK South West, United Kingdom., Knight R; From the Population Health Sciences, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom.; National Institute of Health and Care Research Bristol Biomedical Research Centre, Bristol, United Kingdom.; MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom.; National Institute of Health and Care Research Applied Research Collaboration West, University Hospitals Bristol and Weston, United Kingdom., Curtis HJ; The Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom., Walker AJ; The Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom., Andrews CD; The Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom., Mehrkar A; The Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom., Morley J; The Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom., MacKenna B; The Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom., Bacon SCJ; The Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom., Goldacre B; The Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom., Hernán MA; CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA.; Departments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA., Sterne JAC; From the Population Health Sciences, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom.; National Institute of Health and Care Research Bristol Biomedical Research Centre, Bristol, United Kingdom.; Health Data Research UK South West, United Kingdom.

مؤلفون مشاركون: and the OpenSAFELY collaborative

المصدر: Epidemiology (Cambridge, Mass.) [Epidemiology] 2024 Jul 01; Vol. 35 (4), pp. 568-578. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9009644 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-5487 (Electronic) Linking ISSN: 10443983 NLM ISO Abbreviation: Epidemiology Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , Immunization, Secondary* , BNT162 Vaccine* , 2019-nCoV Vaccine mRNA-1273* , SARS-CoV-2*/immunology , COVID-19 Vaccines*/administration & dosage, Humans ; England/epidemiology ; Male ; Female ; Middle Aged ; Adult ; Aged ; Vaccine Efficacy ; Proportional Hazards Models ; Hospitalization/statistics & numerical data

المؤلفون: Xiang J; Iowa City Veterans Administration Healthcare System, 601 Highway 6, Iowa City, IA 52246, USA; The University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA., Katz L; Impact Life Blood Services, 5500 Lakeview Parkway, Davenport, IA 52807, USA., Winokur PL; The University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA., Chaudhary A; Iowa City Veterans Administration Healthcare System, 601 Highway 6, Iowa City, IA 52246, USA; The University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA., Digmann B; Impact Life Blood Services, 5500 Lakeview Parkway, Davenport, IA 52807, USA., Bradford R; American Type Culture Collection (ATCC), 10801 University Boulevard, Manassas, VA 20110, USA; The Biodefense and Emerging Infections Research Resources Repository (BEI Resources), 10801 University Boulevard, Manassas, VA 20110, USA., Rashid S; American Type Culture Collection (ATCC), 10801 University Boulevard, Manassas, VA 20110, USA; The Biodefense and Emerging Infections Research Resources Repository (BEI Resources), 10801 University Boulevard, Manassas, VA 20110, USA., Ghosh S; American Type Culture Collection (ATCC), 10801 University Boulevard, Manassas, VA 20110, USA; The Biodefense and Emerging Infections Research Resources Repository (BEI Resources), 10801 University Boulevard, Manassas, VA 20110, USA., Robertson A; American Type Culture Collection (ATCC), 10801 University Boulevard, Manassas, VA 20110, USA; The Biodefense and Emerging Infections Research Resources Repository (BEI Resources), 10801 University Boulevard, Manassas, VA 20110, USA., Menetski J; Foundation for the National Institutes of Health, Bethesda, MD 20814, USA., Xu M; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA., Gao P; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA., Chen CZ; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA., Lee T; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA., Poelaert B; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA., Eastman RT; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA., Hall MD; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA., Stapleton JT; Iowa City Veterans Administration Healthcare System, 601 Highway 6, Iowa City, IA 52246, USA; The University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA. Electronic address: jack-stapleton@uiowa.edu.

المصدر: Journal of immunological methods [J Immunol Methods] 2024 Jul; Vol. 530, pp. 113698. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1305440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7905 (Electronic) Linking ISSN: 00221759 NLM ISO Abbreviation: J Immunol Methods Subsets: MEDLINE

مواضيع طبية MeSH: SARS-CoV-2*/immunology , Antibodies, Viral*/blood , Antibodies, Viral*/immunology , COVID-19*/prevention & control , COVID-19*/immunology , COVID-19*/virology , Antibodies, Neutralizing*/blood , Antibodies, Neutralizing*/immunology , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , 2019-nCoV Vaccine mRNA-1273*/immunology , BNT162 Vaccine*/immunology , BNT162 Vaccine*/administration & dosage , Neutralization Tests*, Humans ; Spike Glycoprotein, Coronavirus/immunology ; Reference Standards ; Immunization, Secondary ; Vaccination ; Ad26COVS1/immunology

SCR Organism: SARS-CoV-2 variants

المؤلفون: Dixit A; Moderna, Cambridge, MA, USA. Electronic address: avika.dixit@modernatx.com., Bennett R; Clinical Research Partners, Richmond, VA, USA., Ali K; Texas Center for Drug Development, Houston, TX, USA., Griffin C; Lynn Health Science Institute - ERN - PPDS, Oklahoma City, OK, USA., Clifford RA; Coastal Pediatric Research, Charleston, SC, USA., Turner M; Velocity Clinical Research - Boise - ERN - PPDS, Meridian, ID, USA., Poston R; Moderna, Cambridge, MA, USA., Hautzinger K; Moderna, Cambridge, MA, USA., Yeakey A; Moderna, Cambridge, MA, USA., Girard B; Moderna, Cambridge, MA, USA., Zhou W; Moderna, Cambridge, MA, USA., Deng W; Moderna, Cambridge, MA, USA., Zhou H; Moderna, Cambridge, MA, USA., Schnyder Ghamloush S; Moderna, Cambridge, MA, USA., Kuter BJ; Moderna, Cambridge, MA, USA., Slobod K; Moderna, Cambridge, MA, USA., Miller JM; Moderna, Cambridge, MA, USA., Priddy F; Moderna, Cambridge, MA, USA., Das R; Moderna, Cambridge, MA, USA.

مؤلفون مشاركون: ROVER Study Investigators

المصدر: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Jul; Vol. 24 (7), pp. 687-697. Date of Electronic Publication: 2024 Mar 19.

نوع المنشور: Journal Article; Clinical Trial, Phase III

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19*/immunology , SARS-CoV-2*/immunology , SARS-CoV-2*/genetics , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/adverse effects , COVID-19 Vaccines*/administration & dosage , 2019-nCoV Vaccine mRNA-1273*/immunology , Immunogenicity, Vaccine* , Antibodies, Viral*/blood , Immunization, Secondary*, Humans ; Male ; Female ; Child, Preschool ; Infant ; United States ; Antibodies, Neutralizing/blood ; Vaccination/methods

SCR Organism: SARS-CoV-2 variants

المؤلفون: Gim H; Infectious Disease Research Center, Citizens' Health Bureau, Seoul Metropolitan Government, Seoul, Korea., Seo H; Infectious Disease Research Center, Citizens' Health Bureau, Seoul Metropolitan Government, Seoul, Korea., Chun BC; Department of Epidemiology & Health Informatics, Graduate School of Public Health, Korea University, Seoul, Korea.; Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea. chun@korea.ac.kr.

المصدر: Journal of Korean medical science [J Korean Med Sci] 2024 Jun 03; Vol. 39 (21), pp. e174. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Korean Academy of Medical Science Country of Publication: Korea (South) NLM ID: 8703518 Publication Model: Electronic Cited Medium: Internet ISSN: 1598-6357 (Electronic) Linking ISSN: 10118934 NLM ISO Abbreviation: J Korean Med Sci Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19*/immunology , COVID-19*/epidemiology , SARS-CoV-2*/immunology , SARS-CoV-2*/isolation & purification , BNT162 Vaccine*/immunology , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , Immunization, Secondary* , Vaccine Efficacy* , Reinfection*/prevention & control , Reinfection*/immunology , 2019-nCoV Vaccine mRNA-1273*/immunology, Humans ; Male ; Female ; Case-Control Studies ; Adult ; Middle Aged ; Young Adult ; Vaccination ; ChAdOx1 nCoV-19 ; Aged

المؤلفون: Dalapati T; Medical Scientist Training Program.; Department of Molecular Genetics and Microbiology., Williams CA; Weill Cornell Medicine, Department of Pediatrics, Division of Infectious Diseases, New York, New York., Giorgi EE; Department of Pediatrics, Division of Pediatric Critical Care Medicine.; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington., Hurst JH; Department of Pediatrics, Division of Infectious Diseases.; Department of Pediatrics, Children's Health & Discovery Institute., Herbek S; Weill Cornell Medicine, Department of Pediatrics, Division of Infectious Diseases, New York, New York., Chen JL; Weill Cornell Medicine, Department of Pediatrics, Division of Infectious Diseases, New York, New York., Kosman C; Weill Cornell Medicine, Department of Pediatrics, Division of Infectious Diseases, New York, New York., Rotta AT; Department of Pediatrics, Division of Pediatric Critical Care Medicine., Turner NA; Department of Medicine, Division of Infectious Diseases., Pulido N; Department of Pediatrics, Division of Infectious Diseases., Aquino JN; Department of Pediatrics, Division of Infectious Diseases., Pfeiffer TS; Department of Pediatrics, Division of Infectious Diseases., Rodriguez J; Department of Pediatrics, Children's Clinical Research Unit, Duke University School of Medicine, Durham, North Carolina., Fouda GG; Weill Cornell Medicine, Department of Pediatrics, Division of Infectious Diseases, New York, New York., Permar SR; Weill Cornell Medicine, Department of Pediatrics, Division of Infectious Diseases, New York, New York., Kelly MS; Department of Molecular Genetics and Microbiology.; Department of Pediatrics, Division of Infectious Diseases.

المصدر: Pediatrics [Pediatrics] 2024 Jun 01; Vol. 153 (6).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print Cited Medium: Internet ISSN: 1098-4275 (Electronic) Linking ISSN: 00314005 NLM ISO Abbreviation: Pediatrics Subsets: MEDLINE

مواضيع طبية MeSH: BNT162 Vaccine*/immunology , BNT162 Vaccine*/administration & dosage , 2019-nCoV Vaccine mRNA-1273*/immunology , Antibodies, Neutralizing*/blood , Immunogenicity, Vaccine*/immunology , COVID-19*/prevention & control , COVID-19*/immunology , Antibodies, Viral*/blood, Humans ; Infant ; Child, Preschool ; Male ; Prospective Studies ; Female ; SARS-CoV-2/immunology ; COVID-19 Vaccines/immunology ; COVID-19 Vaccines/administration & dosage ; Cohort Studies ; Spike Glycoprotein, Coronavirus/immunology

المؤلفون: Talib N; Department of Medical Imaging, University Medical Imaging Toronto, University of Toronto, Toronto, Ontario, Canada., Fronza M; Department of Medical Imaging, University Medical Imaging Toronto, University of Toronto, Toronto, Ontario, Canada., Marschner CA; Department of Medical Imaging, University Medical Imaging Toronto, University of Toronto, Toronto, Ontario, Canada., Thavendiranathan P; Department of Medical Imaging, University Medical Imaging Toronto, University of Toronto, Toronto, Ontario, Canada; Division of Cardiology, Peter Munk Cardiac Center, University Health Network, University of Toronto, Toronto, Ontario, Canada; Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada., Karur GR; Department of Medical Imaging, University Medical Imaging Toronto, University of Toronto, Toronto, Ontario, Canada., Hanneman K; Department of Medical Imaging, University Medical Imaging Toronto, University of Toronto, Toronto, Ontario, Canada; Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: katehanneman@uhn.ca.

المصدر: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance [J Cardiovasc Magn Reson] 2024 Summer; Vol. 26 (1), pp. 101036. Date of Electronic Publication: 2024 Mar 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9815616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-429X (Electronic) Linking ISSN: 10976647 NLM ISO Abbreviation: J Cardiovasc Magn Reson Subsets: MEDLINE

مواضيع طبية MeSH: Myocarditis*/diagnostic imaging , Myocarditis*/etiology , COVID-19*/prevention & control , COVID-19*/complications , 2019-nCoV Vaccine mRNA-1273*/administration & dosage , COVID-19 Vaccines*/adverse effects , COVID-19 Vaccines*/administration & dosage , Predictive Value of Tests* , BNT162 Vaccine*/adverse effects , BNT162 Vaccine*/administration & dosage, Humans ; Male ; Adult ; Female ; Retrospective Studies ; Middle Aged ; Magnetic Resonance Imaging, Cine ; Vaccination/adverse effects ; Young Adult ; Time Factors ; SARS-CoV-2 ; Magnetic Resonance Imaging ; Follow-Up Studies ; Ventricular Function, Left